First Patient Dosed in IVIG Study for PI
Source: https://pixabay.com/en/hospital-infusion-drip-antibiotic-834152/

First Patient Dosed in IVIG Study for PI

  According to a July 13 news release, biopharmaceutical company Kedrion Biopharma ("Kedrion") recently treated its first pediatric patient within the Phase 3 KIDCARES10 clinical trial. Within the trial, Kedrion…

Continue Reading First Patient Dosed in IVIG Study for PI
Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!
source: pixabay.com

Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!

Severe Combined Immunodeficiency Severe combined immunodeficiency (SCID) is a group of diseases caused by mutations that affect how the immune system works to fight infections. These anomalies are usually passed…

Continue Reading Free Summit on Severe Combined Immunodeficiency (SCID) Coming Soon!
X-Linked Severe Combined Immunodeficiency: Companies Announce Licensing Agreement for Gene Therapy Tech
source: pixabay.com

X-Linked Severe Combined Immunodeficiency: Companies Announce Licensing Agreement for Gene Therapy Tech

According to a story from BioSpace, SIRION Biotech GmbH and Mustang Bio, Inc. have announced a new agreement for licensing the use of SIRION's proprietary LentiBOOST™ technology for use by…

Continue Reading X-Linked Severe Combined Immunodeficiency: Companies Announce Licensing Agreement for Gene Therapy Tech
Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus
source: pixabay.com

Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus

  Michael and Armené Kapamajian were at home in Los Angeles settling in with their one week old baby, Sasoun, when their doctor called and asked them to come in…

Continue Reading Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus
Gene Therapy Being Assessed for Treatment of X-Linked Severe Combined Immunodeficiency
source: pixabay.com

Gene Therapy Being Assessed for Treatment of X-Linked Severe Combined Immunodeficiency

  Mustang Bio, a biopharmaceutical company, has been working with St. Jude Children's Research Hospital to develop MB-107, a lentiviral gene therapy to treat X-linked severe combined immunodeficiency. Mustang Bio…

Continue Reading Gene Therapy Being Assessed for Treatment of X-Linked Severe Combined Immunodeficiency
FDA Grants Regenerative Medicine Advanced Therapy Designation to Investigational X-Linked SCID Therapy
rawpixel / Pixabay

FDA Grants Regenerative Medicine Advanced Therapy Designation to Investigational X-Linked SCID Therapy

According to a press release from American biotechnology company Fortress Biotech, the American Food and Drug Administration (FDA) recently awarded Regenerative Medicine Advanced Therapy designation to the experimental gene therapy…

Continue Reading FDA Grants Regenerative Medicine Advanced Therapy Designation to Investigational X-Linked SCID Therapy

Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency

SCID Severe combined immunodeficiency (SCID) is a rare disease which causes patients to have little to no immune response. With practically no immune system, SCID patients are very susceptible to…

Continue Reading Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency